Tumor-Treating Fields Inhibit the Metastatic Potential of Osteosarcoma Cells

The prognosis of metastatic osteosarcoma (OS) remains poor with a <20% survival rate, particularly in cases of distant (non-lung) metastases. Tumor-treating field (TTF) therapy is a novel electric field-based treatment that causes metaphase arrest and tumor cell death, with the advantage of reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Ju Yeon, Lee, Yeon-Joo, Kim, Eun Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502799/
https://www.ncbi.nlm.nih.gov/pubmed/32938326
http://dx.doi.org/10.1177/1533033820947481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502799/
https://www.ncbi.nlm.nih.gov/pubmed/32938326
http://dx.doi.org/10.1177/1533033820947481

Ejemplares similares